Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BDP/formoterol versus beclomethasone in adults with uncontrolled asthma
2010-020602-14Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of beclomethasone dipropionate and formoterol in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Change from baseline to the entire treatment period in average pre-dose morning peak expiratory flow. Started Jan 2012; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-020602-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020602-14.